Clinical Trial Update: Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole [Phase 4]

View source ↗

Summary

Open-label Phase 4 study evaluating letrozole in postmenopausal women with ER and/or PgR positive breast cancer; trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED